(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3598.90 | 4835.80 | -25.58 | 3598.90 | 4835.80 | -25.58 | 20305.00 | 25044.30 | -18.92 |
| Other Income | 121.60 | 131.00 | -7.18 | 121.60 | 131.00 | -7.18 | 447.30 | 648.40 | -31.01 |
| PBIDT | 386.50 | 1173.00 | -67.05 | 386.50 | 1173.00 | -67.05 | 4991.40 | 8490.50 | -41.21 |
| Interest | 21.20 | 68.00 | -68.82 | 21.20 | 68.00 | -68.82 | 224.60 | 367.00 | -38.80 |
| PBDT | 365.30 | 1024.00 | -64.33 | 365.30 | 1024.00 | -64.33 | 4472.10 | 7965.70 | -43.86 |
| Depreciation | 343.20 | 313.60 | 9.44 | 343.20 | 313.60 | 9.44 | 1335.80 | 1465.10 | -8.83 |
| PBT | 22.10 | 710.40 | -96.89 | 22.10 | 710.40 | -96.89 | 3136.30 | 6500.60 | -51.75 |
| TAX | 8.00 | 184.70 | -95.67 | 8.00 | 184.70 | -95.67 | 849.20 | 1588.80 | -46.55 |
| Deferred Tax | 8.00 | 3.20 | 150.00 | 8.00 | 3.20 | 150.00 | 68.20 | -124.30 | -154.87 |
| PAT | 14.10 | 525.70 | -97.32 | 14.10 | 525.70 | -97.32 | 2287.10 | 4911.80 | -53.44 |
| Equity | 382.60 | 382.60 | 0.00 | 382.60 | 382.60 | 0.00 | 382.60 | 254.60 | 50.27 |
| PBIDTM(%) | 10.74 | 24.26 | -55.73 | 10.74 | 24.26 | -55.73 | 24.58 | 33.90 | -27.49 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1949.00 |
| Dr. Reddys Labs. | 1172.00 |
| Cipla | 1472.00 |
| Lupin | 2360.00 |
| Zydus Lifesciences | 1115.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: